BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 14,500 shares, a drop of 41.5% from the February 28th total of 24,800 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 15,800 shares, the short-interest ratio is presently 0.9 days.

BetterLife Pharma Stock Down 12.0 %

Shares of BetterLife Pharma stock opened at $0.06 on Monday. BetterLife Pharma has a 52 week low of $0.05 and a 52 week high of $0.15. The business has a 50 day moving average price of $0.08 and a 200-day moving average price of $0.08. The company has a market cap of $7.61 million, a PE ratio of -1.96 and a beta of 1.41.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.